Gene · 325
Papers4,193
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 4,193
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human serum proteins bind to Sporothrix schenckii conidia with differential effects on phagocytosis. | Braz J Microbiol | 2021 | 32382937 | PubTator, text mining | PubMed |
| The complement cascade in Alzheimer's disease: a systematic review and meta-analysis. | Mol Psychiatry | 2021 | 31628417 | PubTator, text mining | PubMed |
| Age-stratified outcomes of bioprosthetic and mechanical aortic valve replacements in an Australian cohort of 13 377 patients. | BMJ Surg Interv Health Technol | 2020 | 35047791 | PubTator, text mining | PubMed |
| Systemic inflammation is negatively associated with early post discharge growth following acute illness among severely malnourished children - a pilot study. | Wellcome Open Res | 2020 | 33969227 | PubTator, text mining | PubMed |
| Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors? | Front Immunol | 2020 | 33664737 | PubTator, text mining | PubMed |
| Proteomic Alterations in Multiple Myeloma: A Comprehensive Study Using Bone Marrow Interstitial Fluid and Serum Samples. | Front Oncol | 2020 | 33585190 | PubTator, text mining | PubMed |
| The Role of PTX3 in Mineralization Processes and Aging-Related Bone Diseases. | Front Immunol | 2020 | 33584725 | PubTator, text mining | PubMed |
| A Proteomic Atlas of Cardiac Amyloid Plaques. | JACC CardioOncol | 2020 | 33511353 | PubTator, text mining | PubMed |
| Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target. | Front Immunol | 2020 | 33505394 | PubTator, text mining | PubMed |
| IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity. | Immunotargets Ther | 2020 | 33447585 | PubTator, text mining | PubMed |
| New Approaches to Identify Sepsis Biomarkers: The Importance of Model and Sample Source for Mass Spectrometry. | Oxid Med Cell Longev | 2020 | 33425215 | PubTator, text mining | PubMed |
| Localised amyloidosis of the bladder: A rare mimic of urinary tract malignancy (case report and literature review). | Int J Surg Case Rep | 2020 | 33395880 | PubTator, text mining | PubMed |
| Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF. | Cells | 2020 | 33383752 | PubTator, text mining | PubMed |
| Pathological Insight into 5-HT2B Receptor Activation in Fibrosing Interstitial Lung Diseases. | Int J Mol Sci | 2020 | 33379351 | PubTator, text mining | PubMed |
| A CD209 ligand and a sialidase inhibitor differentially modulate adipose tissue and liver macrophage populations and steatosis in mice on the Methionine and Choline-Deficient (MCD) diet. | PLoS One | 2020 | 33378413 | PubTator, text mining | PubMed |
| Modulation of Immune Checkpoints by Chemotherapy in Human Colorectal Liver Metastases. | Cell Rep Med | 2020 | 33377131 | PubTator, text mining | PubMed |
Uropathogenic Escherichia coli in the high vaginal swab samples of fertile and infertile women: virulence factors, O-serogroups, and phenotyping and genotyping characterization of antibiotic resistance. | New Microbes New Infect | 2020 | 33364031 | PubTator, text mining | PubMed |
| Modulation of the Mechanisms Driving Transthyretin Amyloidosis. | Front Mol Neurosci | 2020 | 33362465 | PubTator, text mining | PubMed |
| Advances in meningioma genomics, proteomics, and epigenetics: insights into biomarker identification and targeted therapies. | Oncotarget | 2020 | 33346248 | PubTator, text mining | PubMed |
| FCGR1A Serves as a Novel Biomarker and Correlates With Immune Infiltration in Four Cancer Types. | Front Mol Biosci | 2020 | 33344503 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/325/papers?page=44